Dr Deborah Lambie

Investment Analyst
Milford Team Deborah Lambie

Deborah joined Milford in early 2020 as an Investment Analyst covering Global Equities. Prior to joining Milford, Deborah was an Associate in the Investment Banking Team at Jarden where she worked on a number of Mergers and Acquisitions & Equity Capital Markets (ECM) transactions including the sale of Aegis, the sale of TRG Imaging, the purchase of Hellers, and a number of capital raises.

Prior to this, Deborah worked as a medical doctor at Capital & Coast District Health Board, and was Chair of the New Zealand Medical Association Doctors in Training Council. Deborah also has an interest in online education and co-founded LearnCoach with David Cameron in 2015, which is widely used by NCEA students.

Deborah holds a Bachelor of Medicine and Bachelor of Surgery, Bachelor of Medical Science (Honours), Master of Entrepreneurship (Distinction) and is a CFA Charterholder.

Related Articles

Stock Story: Uber

Dr Deborah Lambie,8 March 2024

Uber can be thought of as the largest transportation company in the world. It has been a pioneer in the ride-hailing and broader gig economy. Nowadays, it doesn’t matter which service you are using, whether it is Lyft, Didi or Uber – people say, “I’m going to grab an Uber”- Uber has become a verb […]

Read More

Month in a Minute: December 2023

Dr Deborah Lambie,11 January 2024

A Fast Finish
Funds delivered strong performances in December, building on the positive November to finish the year with solid gains. This performance was driven by broad rallies across shares and bonds as investors fully embrace the soft-landing outcome of falling inflation and positive economic growth.
The last two months of the year were characterised by a […]

Read More

Month in a Minute: June 2023

Dr Deborah Lambie,7 July 2023


Halfway to a soft landing
Inflation is falling whilst economic growth looks to be resilient, delivering what investors have termed a “soft landing”. Last month, markets continued to unwind the scarring effects of the US regional banking crisis. Global shares rallied sharply whilst bonds were modestly lower. Overall, Milford’s funds delivered a positive performance for […]

Read More

Is globalisation dead?

Dr Deborah Lambie,22 December 2022

Last week, Dr Morris Chang, founder of TSMC – the world’s largest contract manufacturer of semiconductor chips, said that he believes globalisation is ‘almost dead’. In this blog, I will delve into current data around globalisation, and the investment implications of this data.
Over the past 150 years, we have seen a significant increase in globalisation, […]

Read More

Stock Story: WillScot Mobile Mini

Dr Deborah Lambie,6 December 2022


WillScot Mobile Mini (WSC) is the market leader in North American modular workplace solutions (around 50% market share) and portable storage solutions (around 25% market share). WSC leases mobile site offices and storage units to almost all industries. Use cases range from providing organisations with a temporary warehouse space to store inventory and portable offices […]

Read More

Biopharma: bolstering protection for our bodies and our portfolios

Dr Deborah Lambie,29 June 2022

2022 has brought with it significant volatility in global share markets. This has been driven by a multitude of factors including: rising inflation; rising interest rates; exchange rate volatility; and geo-political uncertainty. Going forward, the economic outlook remains uncertain, and a 2022/23 recession is a real possibility. Given this, investors have been looking for ‘safe-havens’ […]

Read More

End of content

No more pages to load

Milford's Insights

Subscribe to weekly insights from our investment experts